UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Producción inteligente: Diseño de un modelo para el proceso de implementación de Cadenas de Suministros Inteligentes

Tecnología en marcha, 2020-11, p.ág. 73-82

2020

Link zum Volltext

Verfügbarkeit prüfen

Virtual Cerebral Aneurysm Clipping with Real-Time Haptic Force Feedback in Neurosurgical Education

World neurosurgery, 2018-04, Vol.112, p.e313-e323

2018

Link zum Volltext

Verfügbarkeit prüfen

Isokinetic Leg-Press Power–Force–Velocity Profiles Are Reliable in Male and Female Elite Athletes but Not Interchangeable With Vertical Jump Profiles

International journal of sports physiology and performance, 2022-11, Vol.17 (11), p.1614-1620

2022

Link zum Volltext

Verfügbarkeit prüfen

Isokinetic Strength Profile of Elite Female Handball Players

Journal of human kinetics, 2015-12, Vol.49 (1), p.257-266

2015

Link zum Volltext

Verfügbarkeit prüfen

Comments on “A system for 3D representation of burns and calculation of burnt skin area”

Burns, 2012-11, Vol.38 (7), p.1091-1093

2012

Link zum Volltext

Verfügbarkeit prüfen

Explosive Strength of the Knee Extensors: The Influence of Criterion Trial Detection Methodology on Measurement Reproducibility

Journal of human kinetics, 2016-04, Vol.50 (1), p.15-25

2016

Link zum Volltext

Verfügbarkeit prüfen

Fundamental Framework for Task Mining Technology Adoption: Results from a Qualitative Empirical Study

Proceedings of the 2023 9th International Conference on Computer Technology Applications, 2023, p.50-59

2023

Link zum Volltext

Verfügbarkeit prüfen

Parallel simulation and visualization of blood flow in intracranial aneurysms

2010 11th IEEE/ACM International Conference on Grid Computing, 2010, p.153-160

2010

Link zum Volltext
IEEE_Xplore

The ABC of Ecological Sustainability in C-parts Management. A Maturity Model for the Evaluation of Sustainability in C-parts Management

Towards a Smart, Resilient and Sustainable Industry, p.398-411

Link zum Volltext

Verfügbarkeit prüfen

BurnCase 3D – Realistic Adaptation of 3-Dimensional Human Body Models

Medical Image Computing and Computer-Assisted Intervention – MICCAI 2004, p.363-370

Link zum Volltext

Verfügbarkeit prüfen

Meta-model based knowledge discovery

2011 International Conference on Data and Knowledge Engineering (ICDKE), 2011, p.8-12

2011

Link zum Volltext
IEEE_Xplore

Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study

The lancet oncology, 2020-07, Vol.21 (7), p.978-988

2020

Link zum Volltext

Verfügbarkeit prüfen

Determination of accessibility and spatial distribution of chiral Rh diene complexes immobilized on SBA-15 via phosphine-based solid-state NMR probe molecules

Catalysis science & technology, 2023-01, Vol.13 (2), p.410-425

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-term analyses from L-MIND, a phase II study of tafasitamab (MOR208) combined with lenalidomide (LEN) in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.7513-7513

2021

Link zum Volltext

Verfügbarkeit prüfen

Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor

Leukemia & lymphoma, 2021-12, Vol.62 (14), p.3440-3451

2021

Link zum Volltext

Verfügbarkeit prüfen

Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Blood, 2019-11, Vol.134 (Supplement_1), p.1582-1582

2019

Link zum Volltext

Verfügbarkeit prüfen

Determination of accessibility and spatial distribution of chiral Rh diene complexes immobilized on SBA-15 phosphine-based solid-state NMR probe molecules

Catalysis science & technology, 2023-01, Vol.13 (2), p.41-425

2023

Link zum Volltext

Verfügbarkeit prüfen

Update of the single-arm phase II L-MIND study of MOR208 + lenalidomide (LEN) in relapsed/refractory diffuse large B-cell lymphoma (R-R DLBCL): Response rates in patient subgroups with poor prognosis

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.7521-7521

2019

Link zum Volltext

Verfügbarkeit prüfen

Two-Cohort Phase II Study in R/R CLL (COSMOS): First Preliminary Safety and Efficacy Results of Anti-CD19 MOR208 Treatment in Combination with Venetoclax in Patients Who Discontinued Prior BTK Inhibitor Therapy

Blood, 2018-11, Vol.132 (Supplement 1), p.4433-4433

2018

Link zum Volltext

Verfügbarkeit prüfen

Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind

Blood, 2018-11, Vol.132 (Supplement 1), p.227-227

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Englisch
(27)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(12)
Life Sciences & Biomedicine
(11)
Humans
(5)
Clinical Neurology
(3)
Hematology
(3)
Neurosciences & Neurology
(3)
Sport Sciences
(3)
Adult
(2)
Antibodies
(2)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(2)
Data Visualization
(2)
Dna Methylation
(2)
Dna Modification Methylases - Metabolism
(2)
Dna Repair Enzymes - Metabolism
(2)
Fixatives
(2)
Formaldehyde
(2)
Oncology
(2)
Pathology
(2)
Surgery
(2)
Tissue Fixation - Methods
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Producción inteligente: Diseño de un modelo para el proceso de implementación de Cadenas de Suministros Inteligentes

Virtual Cerebral Aneurysm Clipping with Real-Time Haptic Force Feedback in Neurosurgical Education

Isokinetic Leg-Press Power–Force–Velocity Profiles Are Reliable in Male and Female Elite Athletes but Not Interchangeable With Vertical Jump Profiles

Isokinetic Strength Profile of Elite Female Handball Players

Comments on “A system for 3D representation of burns and calculation of burnt skin area”

Explosive Strength of the Knee Extensors: The Influence of Criterion Trial Detection Methodology on Measurement Reproducibility

Fundamental Framework for Task Mining Technology Adoption: Results from a Qualitative Empirical Study

Parallel simulation and visualization of blood flow in intracranial aneurysms

The ABC of Ecological Sustainability in C-parts Management. A Maturity Model for the Evaluation of Sustainability in C-parts Management

BurnCase 3D – Realistic Adaptation of 3-Dimensional Human Body Models

Meta-model based knowledge discovery

Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study

Determination of accessibility and spatial distribution of chiral Rh diene complexes immobilized on SBA-15 via phosphine-based solid-state NMR probe molecules

Long-term analyses from L-MIND, a phase II study of tafasitamab (MOR208) combined with lenalidomide (LEN) in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)

Long-Term Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study

Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor

Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Determination of accessibility and spatial distribution of chiral Rh diene complexes immobilized on SBA-15 phosphine-based solid-state NMR probe molecules

Update of the single-arm phase II L-MIND study of MOR208 + lenalidomide (LEN) in relapsed/refractory diffuse large B-cell lymphoma (R-R DLBCL): Response rates in patient subgroups with poor prognosis

Two-Cohort Phase II Study in R/R CLL (COSMOS): First Preliminary Safety and Efficacy Results of Anti-CD19 MOR208 Treatment in Combination with Venetoclax in Patients Who Discontinued Prior BTK Inhibitor Therapy

Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind

Primary Analysis of Anti-CD19 Tafasitamab (MOR208) Treatment in Combination with Idelalisib or Venetoclax in R/R CLL Patients Who Failed Prior BTK Inhibitor Therapy (COSMOS Trial)

Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind

A Phase IIa, Open-Label, Multicenter Study of Single-Agent Tafasitamab (MOR208), an Fc-Optimized Anti-CD19 Antibody, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma: Long-Term Follow-up, Final Analysis

Suchergebnisse filtern